Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 21,250
-650 (-2.97%)
Apr 30, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 953.87 billion as of April 30, 2026. Its market cap has increased by 257.78% in one year.
Market Cap
953.87B
Enterprise Value
901.26B
Revenue
53.39B
Ranking
n/a
PE Ratio
60.43
Stock Price
21,250.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 953.87B, an increase of 410.34%. That is a compound annual growth rate of 231.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 953.87B | 9.67% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 1.90T |
| Chabiotech | 1.61T |
| Pharmicell | 1.19T |
| MEDIPOST | 1.09T |
| GI Innovation | 1.06T |
| Medy-Tox | 711.89B |
| Proteina | 669.50B |
| GC Corp. | 631.08B |